Translate the text from English to Welsh.



 
Today, the Joint Committee for Vaccination and Immunisation has published its final advice on the next stage of the COVID\-19 Vaccination programme – the Autumn Booster campaign. This provides us with the much needed clarity to progress to the next phase. I would like to thank the JCVI for their advice. I have accepted this advice, so Wales will begin deployment of the Booster programme from next week.


Some months ago, the JCVI was asked whether a campaign should be launched to give people a booster dose of the COVID\-19 vaccine, as a result of emerging evidence of reduced immunity over time. Following weeks of discussion and consideration of evidence, the JCVI has provided its final advice, which recommends the autumn booster campaign for certain groups; its purpose being to reduce any further incidence of Covid\-19 and maximise protection in those who are most vulnerable to serious infection, ahead of the winter months.


In their final advice, the JCVI recommends that individuals who were eligible and received vaccination in Phase 1 of the COVID\-19 vaccination programme (priority groups 1\-9\) should be offered a third dose COVID\-19 booster vaccine with a minimum 6\-month interval after the 2nd dose. An mRNA vaccine is recommended (Pfizer\-BioNTech or Moderna) irrespective of which vaccine was given as a primary dose.  


The single priority group lists:


* Those living in residential care homes for older adults
* All adults aged 50 years or over
* Frontline health and social care workers
* All those aged 16 to 49 years with underlying health conditions that put them at higher risk of severe COVID\-19 (as set out in the Green Book), and adult carers
* Adult household contacts of immunosuppressed individuals


As most younger adults will only receive their second COVID\-19 vaccine dose in late summer, the benefits of booster vaccination in this group will be considered at a later time, by the JCVI, when more information is available.


There may be opportunities to offer for the COVID\-19 vaccine and flu vaccine to be co\-administered, but this is only where timing and logistics allow.


We have been planning for an autumn booster with health boards over the summer months. I am confident our NHS is ready to deliver this and we will start next week by offering a Booster vaccine to people living and working in care homes and frontline health and social care staff.


It is important that those eligible under the JCVI advice receive a booster dose of the COVID\-19 vaccine, when they are called for an appointment, as there is the possibility of reduced immunity of their previous doses over time.


The vaccine continues to be the best way to prevent serious illness and the spread of COVID\-19 and every eligible adult is urged to take\-up both doses when asked and a booster dose, if eligible.







Translation:


 
Heddiw, mae’r Cyd\-bwyllgor ar Imiwneiddio a Brechu (JCVI) wedi cyhoeddi ei gyngor terfynol ar y cam nesaf yn y rhaglen Frechu rhag COVID\-19 – sef ymgyrch pigiadau atgyfnerthu yn yr hydref. Mae hyn yn rhoi’r eglurder angenrheidiol inni fwrw ymlaen â’r cam nesaf. Hoffwn ddiolch i’r JCVI am ei gyngor. Rwyf wedi derbyn y cyngor hwnnw, felly bydd Cymru yn dechrau rhoi’r rhaglen Pigiadau Atgyfnerthu ar waith wythnos nesaf.


Rai wythnosau yn ôl, gofynnwyd i’r JCVI a ddylid lansio ymgyrch i roi dos atgyfnerthu o frechlyn COVID\-19 i bobl, yn sgil tystiolaeth a oedd yn dod i’r amlwg fod imiwnedd yn lleihau dros amser. Ar ôl trafod ac ystyried y dystiolaeth dros yr wythnosau diwethaf, mae’r JCVI wedi darparu ei gyngor terfynol, gan argymell yr ymgyrch pigiadau atgyfnerthu yn yr hydref ar gyfer grwpiau penodol. Y nod yw lleihau mynychder COVID\-19 ymhellach a sicrhau’r amddiffyniad gorau posibl i’r rhai sydd yn y perygl mwyaf o gael haint difrifol, a hynny cyn misoedd y gaeaf.


Yn ei gyngor terfynol, mae’r JCVI yn argymell y dylai unigolion a oedd yn gymwys ac a gafodd eu brechu yng Ngham 1 o’r rhaglen Frechu rhag COVID\-19 (grwpiau blaenoriaeth 1\-9\) gael cynnig trydydd dos atgyfnerthu o frechlyn COVID\-19\. Bydd angen i o leiaf 6 mis fod wedi bod ers yr ail ddos. Argymhellir brechlyn mRNA (Pfizer\-BioNTech neu Moderna) ni waeth pa frechlyn a roddwyd yn y prif ddos. 


Mae’r grŵp blaenoriaeth yn rhestru:


* Pobl sy’n byw mewn cartrefi gofal preswyl ar gyfer oedolion hŷn
* Pob oedolyn 50 oed a throsodd
* Gweithwyr iechyd a gofal cymdeithasol rheng\-flaen
* Pawb rhwng 16 a 49 oed sydd â chyflyrau iechyd isorweddol sy’n golygu bod mwy o berygl y byddant yn cael COVID\-19 difrifol (fel y nodir yn y Llyfr Gwyrdd), a gofalwyr sy’n oedolion
* Oedolion ar aelwydydd sy’n gysylltiadau i unigolion sydd â llai o imiwnedd


Gan mai dim ond ddiwedd yr haf y cafodd y rhan fwyaf o oedolion ifanc eu hail frechlyn COVID\-19, caiff y manteision o roi pigiad atgyfnerthu i’r grŵp hwn eu hystyried yn ddiweddarach gan y JCVI, pan fydd mwy o wybodaeth ar gael.


Mae’n bosibl y bydd cyfleoedd i roi’r brechlyn COVID\-19 a’r brechlyn ffliw gyda’i gilydd, ond dim ond pan fydd yr amser a’r logisteg yn caniatáu hynny.


Rydym wedi bod yn cynllunio gyda byrddau iechyd dros fisoedd yr haf i gael rhaglen pigiadau atgyfnerthu yn yr hydref. Rwy’n hyderus bod ein GIG yn barod i ddarparu’r rhaglen hon, a byddwn yn dechrau yr wythnos nesaf drwy gynnig pigiad atgyfnerthu i bobl sy’n byw ac yn gweithio mewn cartrefi gofal a staff iechyd a gofal cymdeithasol rheng\-flaen.


Mae’n bwysig bod y rheini sy’n gymwys yn unol â chyngor y JCVI yn cael dos atgyfnerthu’r brechlyn COVID\-19 pan cânt eu galw i gael apwyntiad, gan fod posibilrwydd bod imiwnedd eu dosau blaenorol yn lleihau dros amser.


Y brechlyn yw’r ffordd orau o hyd i atal salwch difrifol ac atal COVID\-19 rhag lledaenu, a chaiff pob oedolyn cymwys ei annog i gael y ddau ddos, a’r dos atgyfnerthu pan ofynnir iddynt, os ydynt yn gymwys.